A leucine zipper motif in the cytoplasmic domain of gp41 is required for HIV-1 replication and pathogenesis in vivo

Virology

Volumn 289, Issue 2, 2001, Pages 208-217

  Kao, Sandra M ^a   Miller, Eric D ^a,b   Su, Lishan ^a,b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENVELOPE PROTEIN; GLYCOPROTEIN GP 41; LEUCINE ZIPPER PROTEIN;

ARTICLE; CONTROLLED STUDY; CYTOPLASM; EMBRYO; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; MONONUCLEAR CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN MOTIF; SCID MOUSE; SIMIAN IMMUNODEFICIENCY VIRUS; VIRION; VIRUS INFECTIVITY; VIRUS MUTANT; VIRUS PATHOGENESIS; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 0035950601     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2001.1112     Document Type: Article

References (36)

1. Epitope mapping and topology of baculovirus-expressed HIV-1 gp160 determined with a panel of murine monoclonal antibodies
2. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone
3. Cell-dependent requirement of human immunodeficiency virus type 1 gp41 cytoplasmic tail for Env Incorporation into virions
4. Human immunodeficiency virus type 1 cell cycle control: Vpr is cytostatic and mediates G2 accumulation by a mechanism which differs from DNA damage checkpoint control
5. Interruption of T-cell signal transduction by lentivirus lytic peptides from HIV-1 transmembrane protein
6. A membrane-proximal tyrosine-based signal mediates internalization of the HIV-1 envelope glycoprotein via interaction with the AP-2 clathrin adaptor
7. Characterization of an HIV-1 isolate displaying an apparent absence of virion-associated reverse transcriptase activity
8. Synergistic inhibition of human immunodeficiency virus type 1 envelope glycoprotein-mediated cell fusion and infection by an antibody to CD4 domain 2 in combination with anti-gp120 antibodies
9. Development of a sensitive quantitative focal assay for human immunodeficiency virus infectivity
10. Macrophage-tropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-cell-tropic isolates: Definition of critical amino acids involved in cell tropism
11. Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes
12. AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor
13. Truncation of the human immunodeficiency virus type 1 transmembrane glycoprotein cytoplasmic domain blocks virus infectivity
14. Effects of deletions in the cytoplasmic domain on biological functions of human immunodeficiency virus type 1 envelope glycoproteins
15. Truncations of the simian immunodeficiency virus transmembrane protein confer expanded virus host range by removing a blocks to virus entry into cells
16. The cytoplasmic domain of HIV-1 gp41 interacts with the carboxyl-terminal region of α-catenin
17. A leucine zipper-like sequence from the cytoplasmic tail of the HIV-1 envelope glycoprotein binds and perturbs lipid bilayers
18. Significance of premature stop codons in env of simian immunodeficiency virus
19. Induction of MHC class I expression on immature thymocytes in HIV-1-infected SCID-hu Thy/Liv mice: Evidence of indirect mechanisms
20. Role of the carboxy-terminal portion of the HIV-1 transmembrane protein in viral transmission and cytopathogenicity
21. The membrane-proximal intracytoplasmic tyrosine residue of HIV-1 envelope glycoprotein is critical for basolateral targeting of viral budding in MDCK cells
22. Rescue of human immunodeficiency virus type 1 matrix protein mutants by envelope glycoproteins with short cytoplasmic domains
23. A structural correlation between lentivirus transmembrane proteins and natural cytolytic peptides
24. Identification of a calmodulin-binding and inhibitory peptide domain in the HIV-1 transmembrane glycoprotein
25. The long cytoplasmic tail of gp41 is required in a cell type-dependent manner for HIV-1 envelope glycoprotein incorporation into virions
26. Genes regulating HLA class I antigen expression in T-B lymphoblast hybrids
27. Expression and characterization of glycophospholipid-anchored human immunodeficiency virus type 1 envelope glycoproteins
28. Bicyclams, a class of potent anti-HIV agents, are targeted at the HIV coreceptor Fusin/CXCR-4
29. Monoclonal antibody and enzymatic profiles of 2human malignant T-lymphoid cells and derived cell lines
30. Cytosolic domain of the human immunodeficiency virus envelope glycoproteins binds to calmodulin and inhibits calmodulin-regulated proteins
31. HIV-1-induced thymocyte depletion is associated with indirect cytopathogenicity and infection of progenitor cells in vivo
32. Indicator cell lines for detection of primary strains of human and simian immunodeficiency viruses
33. Modulation of HIV-1 replication by a novel RhoA effector activity
34. Retained in vitro infectivity and cytopathogenicity of HIV-1 despite truncation of the C-terminal tail of the env gene product
35. Mutations in the cytoplasmic domain of human immunodeficiency virus type 1 transmembrane protein impair the incorporation of Env proteins into mature virions
36. Functional interaction between the cytoplasmic leucine-zipper domain of HIV-1 gp41 and p115-RhoGEF